Calidi's CLD-401 Eradicates Tumors in 80% of Mice in Preclinical Study
Calidi reported that its CLD-401 therapy eradicated tumors in 80% of mice in a preclinical breast cancer study.
Calidi reported that its CLD-401 therapy eradicated tumors in 80% of mice in a preclinical breast cancer study.